Multivariate survival analysis of children with medulloblastoma - A single-center experience

Shih Hsiang Chen, Li Yu Liu, Tang Her Jaing, Chen Kan Tseng, Kuang Lin Lin, Tai Ngar Lui

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


The authors sought to evaluate the treatment outcome of children with medulloblastoma at a single institution. Forty-two children were analyzed. Eighty-six percent of the children who received chemotherapy were treated with cisplatin-based chemotherapy. No factors were found to affect outcome significantly. Compared with children treated before 1994 at the same institution, the median survival time was significantly longer (40 vs. 25 months, p =.0003). The authors conclude that some improvement of treatment outcome for children with medulloblastoma seemed to be achieved.

Original languageEnglish
Pages (from-to)647-654
Number of pages8
JournalPediatric Hematology and Oncology
Issue number7
Publication statusPublished - Sept 2008
Externally publishedYes


  • Children
  • Medulloblastoma
  • Outcome
  • Survival
  • Treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology


Dive into the research topics of 'Multivariate survival analysis of children with medulloblastoma - A single-center experience'. Together they form a unique fingerprint.

Cite this